Fig. 3
From: Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Hazards ratios for cardiovascular events per SD higher PCSK9 level, adjusted for cardiovascular risk factors
Fig. 3 | Journal of Translational Medicine